To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Blood: Contamination
Monday 5th January 2015

Asked by: Joan Ruddock (Labour - Lewisham, Deptford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what progress his Department has made on dealing with claims for compensation by haemophiliacs given contaminated blood provided by the NHS; and if he will make a statement.

Answered by Jane Ellison

Work on what can be done to improve the system of support for those affected by HIV or hepatitis C through historic treatment with NHS supplied blood or blood products is ongoing. We also wish to consider the final report of Lord Penrose’s Public Inquiry in Scotland before making a statement on the way forward.


Written Question
Female Genital Mutilation: Greater London
Monday 27th October 2014

Asked by: Joan Ruddock (Labour - Lewisham, Deptford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how many patients treated at hospitals in South East London were known or suspected to have been subject to female genital mutilation in the last five years for which figures are available.

Answered by Jane Ellison

The information is not available in the format requested. Such information as is available is in the following table:

Active caseload2

Newly identified3

Hospital Trusts in South East London6

337

52

Source: Female Genital Mutilation Prevalence Dataset (ISB 1610)

Notes

1. The data is from the Female Genital Mutilation Prevalence Dataset (ISB 1610), a monthly return of data from acute hospital providers in England. It is an aggregated return of the incidence of FGM including women who have been previously identified and are currently being treated (for FGM related or non FGM related conditions as at the end of the month) and newly identified women within the reporting period. It has been a mandated collection from 1 September 2014. The first statistics from the Female Genital Mutilation Prevalence Dataset (ISB 1610) were published on 16 October 2014.

2. Patients identified as having a history of any FGM type prior to the reporting period and still being actively seen/treated for FGM-related conditions or any other non-related condition at the end of the month. Note: does not include those patients within NUMBER OF PATIENTS WITH FGM NEWLY IDENTIFIED IN REPORTING PERIOD (i.e. identified within this reporting period).

3. Patients first identified during the reporting period as having undergone FGM. This will include those diagnosed/identified within the provider within the month.

4. Data was submitted by trusts between the first and the tenth of October inclusive.

5. Only data that was submitted and signed off has been included.

6. 'Hospital Trusts in South East London' has been defined as: Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Oxleas NHS Foundation Trust, South London and Maudsley NHS Foundation Trust. Only three of these trusts submitted data: Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust.


Written Question
Cancer: Greater London
Thursday 19th June 2014

Asked by: Joan Ruddock (Labour - Lewisham, Deptford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how many patients who were referred by GPs for tests for suspected cancers at (a) Lewisham Hospital, (b) Queen Elizabeth Hospital Woolwich, (c) Guys and St Thomas' Hospital and (d) Kings College Hospital were not seen within six weeks of referral in the last six months.

Answered by Jane Ellison

The information is not available centrally. Whilst information is collected and published every month on waiting times and activity for 15 key diagnostic tests, the data does not identify whether the tests were for suspected cancers or other conditions.